EUVIMEDEUVIMED entdecken
LeserbriefRandomisierte kontrollierte Studie

Letter by Ko et al Regarding Article, “Safety of Switching From a Vitamin K Antagonist to a Non–Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial”

Darae Ko iD, Dae Hyun Kim iD, Daniel E Singer iD

Circulation · 2024

DOI: 10.1161/circulationaha.123.067600 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Circulation, 2024. Verfasst von Darae Ko und 2 weiteren Autor:innen. Beteiligte Einrichtung: Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife and Harvard Medical School, Boston, MA (D.K., D.H.K.). Hauptthemen laut MEDLINE: Atrial Fibrillation, Anticoagulants, Vitamin K, Frail Elderly. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 4 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationAnticoagulantsVitamin KFrail ElderlyHumansAgedAdministration, OralRandomized Controlled Trials as TopicDrug SubstitutionAged, 80 and over

Substanzen

AnticoagulantsVitamin K

Autor:innen und Institutionen

  • Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife and Harvard Medical School, Boston, MA (D.K., D.H.K.).
  • Section of Cardiovascular Medicine, Boston Medical Center, MA (D.K.).
  • Division of Gerontology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA (D.H.K.).
  • Division of General Internal Medicine, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston (D.E.S.).

ORCID-Profile: Darae Ko, Dae Hyun Kim, Daniel E Singer

Zitieren

APA

Ko, D., Kim, D. H., & Singer, D. E. (2024). Letter by Ko et al Regarding Article, “Safety of Switching From a Vitamin K Antagonist to a Non–Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial”. Circulation. https://doi.org/10.1161/circulationaha.123.067600

Vancouver

Ko D, Kim DH, Singer DE. Letter by Ko et al Regarding Article, “Safety of Switching From a Vitamin K Antagonist to a Non–Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial”. Circulation. 2024. doi:10.1161/circulationaha.123.067600

BibTeX
@article{Ko2024,
  author = {Ko, Darae and Kim, Dae Hyun and Singer, Daniel E},
  title = {Letter by Ko et al Regarding Article, “Safety of Switching From a Vitamin K Antagonist to a Non–Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial”},
  journal = {Circulation},
  year = {2024},
  doi = {10.1161/circulationaha.123.067600}
}
Kostenlos starten →